Health
Vaccine candidate containing tetanus toxoid potentially protective against SARS-CoV-2 – News-Medical.Net
Researchers from Cuba, China, and France have demonstrated the potential of coupling a viral antigen with the tetanus toxoid protein as a vaccination approach to…
Researchers from Cuba, China, and France have demonstrated the potential of coupling a viral antigen with the tetanus toxoid protein as a vaccination approach to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
Tetanus toxoid (TT) is a chemically inactivated version of the tetanus toxin produced by the bacteria Clostridium tetani. This chemically inactivated antigen can be used as a protein carrier in vaccines to induce potent…
-
Business10 hours agoTop brokers name 3 ASX shares to buy next week 25 May 2025
-
General21 hours agoZoe Daniel calls for election recount in Goldstein after final count gives Liberal Party’s Tim Wilson 260-vote lead
-
Noosa News20 hours ago‘Stranded’ Eddie the echidna thought to have swum from Bribie Island’s broken tip
-
General19 hours agoFamily describes missing teen Pheobe Bishop as ‘strong-willed’, as items found near Bundaberg bushland